Geneva
Switzerland
8
2020-02-06
5
2021-07-27
These are the the leading inventors for applications assigned to Addex Pharmaceuticals S.A.:
Addex Pharmaceuticals S.A. based in Geneva, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′]bipyridinyl-2′-ones
#2 | 2013-08-01 ✅ Patent 9,132,122 granted on 2015-09-151′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro--[1,4′]bipyridinyl-2′-ones
#3 | 2013-08-011',3'-DISUBSTITUTED-4-PHENY-3,4,5,6-TETRAHYDRO-2H,1'H-[1,4']BIPYRIDINYL-2'-ONES
#4 | 2013-05-02NOVEL PYRIDINONE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2-RECEPTORS
#5 | 2009-05-14 ✅ Patent 8,101,637 granted on 2012-01-24Alkynyl derivatives as modulators of metatropic glutamate receptors
#6 | 2008-01-03Novel aminopyridine derivatives as mGluR5 antagonists
#7 | 2007-09-13 ✅ Patent 8,399,493 granted on 2013-03-19Pyridinone derivatives and their use as positive allosteric modulators of mGluR2-receptors
#8 | 2006-02-09 ✅ Patent 7,205,411 granted on 2007-04-17Aminopyridine derivatives as mGluR5 antagonists
20768 ⎘